1.Relationship between occupational health literacy and occupational stress among workers in mining and manufacturing: Based on LASSO-multilevel logistic regression
Haiya ZHANG ; Wenli ZHAO ; Shuyue WANG ; Yuhong HE ; Jialong WU
Journal of Environmental and Occupational Medicine 2026;43(2):182-188
Background Health literacy is closely related to mental health, and improving health literacy has been shown to promote mental well-being. However, whether occupational stress among workers in mining and manufacturing is associated with their occupational health literacy remains inconclusive. Objective To study the levels of occupational health literacy and occupational stress among workers in three industrial sectors (metal ores mining, metal smelting, and manufacture of non-metallic mineral products) in Gansu Province, and to analyze the correlation between them. Methods Between May and December 2024, a stratified cluster random sampling method was employed to survey workers from 73 large, medium, and small and micro sized enterprises across the aforementioned industries in Gansu Province. Participants’ occupational health literacy and occupational stress levels were assessed. The LASSO regression model was applied to identifykey factors influencing occupational stress, and subsequently a multilevel random intercept mixed-effects logistic model was used to study factors influencing occupational stress and to explore the relationship between occupational health literacy and occupational stress. Results A total of
2.Pharmacological Effect and Mechanism of Volatile Oil Microemulsion of Atractylodes chinensis in Relieving Depression
Xinxing HU ; Shuyue ZHAO ; Chunping XIAO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(9):144-153
ObjectiveTo investigate the therapeutic effects and potential mechanisms of Atractylodes chinensis volatile oil microemulsion in relieving depression, thus establishing a theoretical foundation and a new approach for developing it as a novel adjunctive antidepressant. MethodsSixty SD male rats were assigned into four groups: control, model (chronic unpredictable mild stress), positive drug (flupentixol hydrochloride, 1.8 mg·kg-1), and low-, medium-, high-dose (16.2, 32.4, 64.8 mg·kg-1) A. chinensis volatile oil microemulsion. The sucrose preference test, open field test, tail suspension test, and forced swimming test were conducted to measure the sucrose preference rate, total exercise distance, average speed, resting time, tail suspension time, and swimming immobility time before and after treatment. The morphology of the rat brain tissue was visualized by hematoxylin-eosin (HE) staining. The levels of 5-hydroxytryptamine (5-HT), norepinephrine (NE), and cortisol (CORT) in the hippocampal tissue were measured by enzyme-linked immunosorbent assay (ELISA). Real-time PCR was used to detect mRNA level differences of cyclic adenosine monophosphate (cAMP), protein kinase A (PKA), cyclic adenosine monophosphate response element-binding protein (CREB), brain-derived neurotrophic factor (BDNF), and tyrosine kinase B (TrkB) in the hippocampus. Western blot was employed to assess protein level variations of cAMP, PKA, CREB, BDNF, and TrkB in the same tissue samples. ResultsCompared with that in the blank group, the body mass of rats in low-, medium-, high-dose A. chinensis volatile oil emulsion groups decreased (P<0.05), indicating that the modeling was successful. Compared with the model group, medium-, high-dose A. chinensis volatile oil emulsion shortened the tail suspension time, swimming immobility time, and resting time (P<0.05, P<0.01), while increasing the sucrose preference rate, total exercise distance, and average speed (P<0.01). No significant changes were observed in the low-dose A. chinensis volatile oil emulsion group. ELISA results indicated that CORT concentrations in the hippocampal tissue of medium and high-dose A. chinensis volatile oil emulsion groups decreased (P<0.01). In the high-dose group, 5-HT and NE concentrations increased (P<0.05, P<0.01), while they had no significant changes in the low-dose group. Real-time PCR results revealed that the mRNA levels of cAMP, PKA, and CREB in the hippocampus of the medium-dose Beicangzhu volatile oil emulsion group increased (P<0.05, P<0.01), and those of cAMP, PKA, CREB, BDNF, and TrkB were upregulated in the high-dose Beicangshu volatile oil microemulsion group (P<0.01). Western blot and immunofluorescence results demonstrated that the protein levels of cAMP, PKA, and TrkB in the hippocampal tissue of the low-dose A. chinensis volatile oil microemulsion group were up-regulated (P<0.05). The medium-dose Beicangzhu volatile oil emulsion group exhibited increases in protein levels of cAMP, PKA, BDNF, and TrkB (P<0.05, P<0.01), while the high-dose group showed elevationsin protein levels of cAMP, PKA, CREB, BDNF, and TrkB (P<0.05, P<0.01). ConclusionBeicangzhu volatile oil emulsion demonstrates certain antidepressant efficacy by inhibiting CORT expression, upregulating the expression of 5-HT, NE, cAMP, PKA, CREB, BDNF, and TrkB, activating the CREB/BDNF signaling pathway to improve the cerebral protection.
3.Ancient and Modern Literature Analysis and Key Information Textual Research of Famous Classical Formula Qingzao Jiufeitang
Shuyue FAN ; Xuanyu CHEN ; Yilin ZHAO ; Shaoyuan LIU ; Xueyong HOU ; Luna YU ; Jiyao ZHANG ; Yansong ZHAO
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(24):168-178
Qingzao Jiufeitang is a famous classical formula for treating lung injury caused by warm and dryness, included in the Catalogue of Ancient Famous Classical Formulas(The First Batch). By systematically organizing ancient and modern literature on this formula, this study analyzed and verified the origin, medicinal composition, original plants and processing, dosage and decoction method, efficacy and application of this formula. According to the research, Qingzao Jiufeitang was first recorded in Yimen Falyu in the Qing dynasty, and its creation was mainly inspired by the Ming dynasty physician MIAO Xiyong's idea of the moisturizing drugs with sweet flavour and cold nature. Based on the 2020 edition of the Pharmacopoeia of the People's Republic of China(hereinafter referred to as the Chinese Pharmacopoeia) and the textual research results of modern scholars on traditional Chinese herbal medicines, the botanical sources and processing methods of the herbs in this formula are basically clarified. Among them, Mori Folium, Gypsum Fibrosum, Ginseng Radix et Rhizoma, Sesami Semen Nigrum, Asini Corii Colla, Ophiopogonis Radix and Eriobotryae Folium are consistent with the 2020 edition of the Chinese Pharmacopoeia. The primary source of Glycyrrhizae Radix et Rhizoma is the dried roots and rhizomes of Glycyrrhiza uralensis, family Leguminosae, while the primary source of Armeniacae Semen Amarum is the dried mature seeds of Prunus armeniaca, family Rosaceae. It is recommended to use Gypsum Ustum, stir-fried Sesami Semen Nigrum, stir-fried Armeniacae Semen Amarum, Asini Corii Colla bead, and honey-fried Eriobotryae Folium, and the rest of the raw products. According to the conversion of ancient and modern doses, the recommended dosages are 11.19 g for Mori Folium, 9.33 g for Gypsum Fibrosum, 3.73 g for Glycyrrhizae Radix et Rhizoma, 2.61 g for Ginseng Radix et Rhizoma, 3.73 g for Sesami Semen Nigrum, 4.48 g for Ophiopogonis Radix, 2.61 g for Armeniacae Semen Amarum, 3.73 g for Eriobotryae Folium. The decoction method is to add 300 mL of water, decoct it down to 180 mL, remove the residue, and then add 2.98 g of Asini Corii Colla into the decoction. Take it warm after meals, two to three times a day. Qingzao Jiufeitang has the effects of clearing dryness and moistening the lungs, nourishing Yin and invigorating Qi. In ancient times, it was mainly used to treat stagnation and depression of various Qi, as well as paralysis, asthma and vomiting. In modern clinical practice, it is mostly used to treat diseases in respiratory system, otolaryngology, skin system and digestive system caused by warm-dry impairing lung, deficiency of both Qi and Yin. The above research results can provide a reference for the later development of Qingzao Jiufeitang.
4.Analysis on risk factors of adverse events after non-sedated esophagogastroduo-denoscopy
Shuyue YANG ; Sifan LIU ; Xu JI ; Mengran ZHAO ; Zheng ZHANG ; Peng LI
Journal of Capital Medical University 2025;46(4):676-681
Objective To investigate the risk factor for adverse events(AEs)after non-sedated esophagogastroduodenoscopy(EGD).Methods The data on clinical manifestations,adverse events after non-sedated EGD and common risk factors were collected and retrospectively analyzed with statistical methods in patients who underwent non-sedated EGD from May 2018 to June 2019.These patients were divided into AEs group and non-AEs group.Results Of 2 384 patients,57.67%(1 375/2 384)presented with nausea,12.79%(305/2 384)vomiting,and 5.79%(138/2 384)presented with pharyngalgia.Multivariate Logistic regression analysis was performed.Advanced age(≥65 years old)(OR=0.683,95%CI:0.506-0.921)was protective factors for nausea after non-sedated EGD.Hypertension(OR=1.361,95%CI:1.026-1.806),overweight(OR=1.399,95%CI:1.154-1.695),obesity(OR=2.594,95%CI:1.760-3.823)and inspection duration>15 min(OR=3.107,95%CI:2.296-4.206)were independent risk factors for nausea after non-sedated EGD.Advanced age(OR=0.393,95%CI:0.221-0.699)and imported equipment(OR=0.697,95%CI:0.546-0.890)were protective factors for vomiting after non-sedated EGD.Moreover,inspection duration>15 min(OR=1.641,95%CI:1.008-2.699)was independent risk factors for vomiting after non-sedated EGD.There was no difference in success rate of non-sedated EGD between two groups(P<0.05).Conclusion Hypertension,overweight and obesity were independent risk factors for nausea after non-sedated EGD.The advanced age and imported equipment were protective factors for vomiting after non-sedated EGD.In addition,inspection duration over 15 min is a risk factor for AEs such as nausea and vomiting after nonsedative EGD.Whether AEs occurred or not is non-related to success rate of non-sedated EGD.
5.Advances in cancer stem cell markers and their targeting aptamers.
Shangyang PAN ; Wenjing ZHANG ; Xiaoyang CHEN ; Yan LIU ; Ruolan CHEN ; Shuyue MENG ; Zhao YANG
Chinese Journal of Biotechnology 2025;41(8):3008-3020
Cancer ranks as the second leading cause of death globally and has surpassed cardiovascular diseases to become the primary cause of mortality in developed countries. Cancer stem cells (CSCs), which play crucial roles in cancer recurrence, metastasis, and drug resistance, have attracted significant attention in targeted therapeutic strategies. Aptamers, with unique three-dimensional structures capable of specifically recognizing the surface markers of CSCs, show promising potential in targeted drug delivery systems. Compared with conventional antibodies, aptamers are praised for small molecular weights, low production costs, and easy chemical modification. This review systematically summarizes recent advances in aptamer research targeting the surface markers of CSCs, with particular emphasis on aptamer-drug conjugate systems targeting the markers including EpCAM, CD133, CD44, and ABCG2. Both in vitro cellular studies and in vivo animal models have demonstrated the definite anti-cancer efficacy of aptamer-based drug delivery systems, which are of great significance to develop novel therapeutic strategies and improving the therapeutic effects of CSC-targeted treatment. Thus, aptamer-based drug delivery system has broad application prospects in the field of precise cancer treatment.
Humans
;
Neoplastic Stem Cells/metabolism*
;
Aptamers, Nucleotide/therapeutic use*
;
Drug Delivery Systems/methods*
;
Neoplasms/drug therapy*
;
Biomarkers, Tumor/metabolism*
;
Animals
;
Epithelial Cell Adhesion Molecule
;
AC133 Antigen
;
Hyaluronan Receptors
6.Human umbilical cord mesenchymal stem cell-derived exosomes loaded with miR-132-3p promote skin wound healing.
Shuyue MENG ; Xiaoning LI ; Zhao YANG ; Lei WANG
Chinese Journal of Biotechnology 2025;41(8):3110-3121
Chronic non-healing wounds significantly impair patient rehabilitation and remain a critical clinical challenge. Stem cell-derived exosomes, owing to their biocompatibility and physiological activity, have emerged as a promising therapeutic approach in regenerative medicine. Beyond their intrinsic wound-healing properties, exosomes are increasingly explored as carriers for small-molecule drugs to enhance synergistic treatment effects. Although microRNAs (miRNAs) exhibit potential in promoting cell proliferation and re-epithelialization, their clinical application is hindered by poor stability. In this study, we investigated the therapeutic effects of miR-132-3p-loaded human umbilical mesenchymal stem cell-derived exosomes (miR-132-3p@UMSC-EXOs) on human foreskin fibroblast-1 (HFF-1). Our findings demonstrated that miR-132-3p@UMSC-EXOs significantly enhanced proliferation and migration of HFF-1, while reducing intracellular reactive oxygen species (ROS) levels compared with unloaded exosomes. Furthermore, qRT-PCR and Western blotting analyses revealed that miR-132-3p@UMSC-EXOs modulated the expression of genes associated with extracellular matrix (ECM) remodeling and inflammation, suggesting their potential to upregulate collagen synthesis and improve ECM metabolism. These results highlight the therapeutic promise of miR-132-3p@UMSC-EXOs in accelerating wound healing.
Humans
;
MicroRNAs/pharmacology*
;
Exosomes/metabolism*
;
Mesenchymal Stem Cells/cytology*
;
Wound Healing
;
Umbilical Cord/cytology*
;
Cell Proliferation
;
Fibroblasts/cytology*
;
Skin/injuries*
;
Cell Movement
;
Reactive Oxygen Species/metabolism*
;
Cells, Cultured
7.Observation on the therapeutic effect of atezolizumab combined with anlotinib in treating advanced non-small cell lung cancer
Fang ZHAO ; Guorong JIANG ; Shuyue SHI ; Jian XIAO ; Shaolin MA ; Runpu LI
Journal of International Oncology 2025;52(8):495-501
Objective:To explore the efficacy of atezolizumab combined with anlotinib in treating advanced non-small cell lung cancer (NSCLC) .Methods:A total of 80 patients with advanced NSCLC treated in the Baoding No.2 Central Hospital from September 2019 to September 2023 after second-line treatment were selected as research subjects. Patients who received only anlotinib treatment were included in the monotherapy group ( n=40), while patients who received atezolizumab combined with anlotinib treatment were included in the combination group ( n=40). The clinical efficacy and serum levels of carcinoembryonic antigen (CEA) and vascular endothelial growth factor (VEGF) of the two groups were compared. Kaplan-Meier survival curve was used to analyze the survival of the two groups. The functional assessment of cancer therapy-lung cancer (FACT-L) was used to assess the quality of life of patients in both groups before and after treatment. The incidence of adverse reactions was compared between the two groups. Results:After four cycles of treatment, the objective response rate (ORR) of the combination group was 37.50% (15/40), which was higher than that of the monotherapy group [17.50% (7/40) ], with a statistically significant difference ( χ2=4.01, P=0.045). The disease control rates (DCRs) of the two groups were 85.00% (34/40) and 75.00% (30/40), respectively, with no statistically significant difference ( χ2=1.25, P=0.264). Before treatment, the CEA levels in combination group and monotherapy group were (10.18±2.15) and (10.14±2.02) μg/L, and the VEGF levels were (804.04±46.58) and (809.10±43.63) ng/L, respectively, with no statistically significant difference (both P>0.05). After treatment, the serum CEA levels of patients in combination group and monotherapy group were (4.35±1.05) and (6.63±1.37) μg/L, and the VEGF levels were (431.26±50.19) and (549.92±55.27) ng/L, respectively, with statistically significant differences ( t=8.35, P<0.001; t=10.05, P<0.001), and the levels of serum CEA and VEGF in the two groups after treatment were lower than before treatment ( t=32.47, P<0.001; t=21.73, P<0.001; t=88.65, P<0.001; t=58.27, P<0.001). Survival analysis showed that the median progression-free survival (PFS) of the monotherapy group and the combination group were 4.12 and 6.06 months, respectively, with a statistically significant difference ( χ2=17.70, P<0.001), the median overall survival (OS) were 11.8 and 12.7 months, respectively, with no statistically significant difference ( χ2=3.09, P=0.079). Before treatment, the FACT-L scores of patients in combination group and monotherapy group were 61.20±6.98 and 60.52±7.14, respectively, with no statistically significant difference ( t=0.43, P=0.668). After treatment, the FACT-L scores of the two groups were 83.24±9.38 and 74.58±7.86, respectively, with a statistically significant difference ( t=4.48, P<0.001), and the FACT-L scores of the two groups after treatment were all higher than before treatment ( t=29.36, P<0.001; t=21.51, P<0.001). During treatment, the total incidence of drug-related adverse reactions in two groups was 42.50% (17/40) and 55.00% (22/40), respectively, with no statistically significant difference ( χ2=1.25, P=0.263) . Conclusions:Atezolizumab combined with anlotinib in the treatment of advanced NSCLC can enhance the short-term efficacy, prolong the PFS of patients, improve the quality of life, and the related adverse reactions are tolerable.
8.Multidisciplinary Patrol Supervision of Nursery Services Focusing on the Plan-Do-Check-Act Cycle:Exploration and Practice Based on the Integration of Medical Care and Education
Mutian QIAO ; Jie PU ; Shuyue XIAO ; Yaguo ZHANG ; Lin ZHANG ; Xue XIAO ; Yan HAO ; Li ZHAO
Journal of Sichuan University (Medical Sciences) 2025;56(2):484-488
Nursery services are a vital component of childcare for infants and toddlers.The quality and management of nursery services significantly impact the holistic development of infants and toddlers in terms of their physical,psychological,and social skills and capabilities.The first 1000 days in the life of an infant or toddler are a critical period that shapes their health status for their whole life,which highlights the need to prioritize health in childcare for infants and toddlers and to approach daily childcare services from a medical perspective.Based on the approach of integrating medical care and education,we innovatively explored and constructed a multidisciplinary patrol supervision model for childcare services,focusing on the PDCA cycle(Plan-Do-Check-Act cycle).We aim at establishing a multidisciplinary team of medical and nursing experts who provide evaluation and guidance for the institutional management,health management for infants and toddlers,disease prevention,and risk identification and screening of childcare services for infants and toddlers.This approach addresses the issue of the simplistic nature of the traditional patrol supervision involving only childcare physicians,improves service quality with high efficiency,meets the expectations of both childcare service providers and the families of infants and toddlers-the users of childcare services,enhances the effective implementation of childcare for infants and toddlers based on the integration of medical care and education,and improves the quality of a health-centered approach to childcare for infants and toddlers.
9.Septic shock caused by Shewanella algae bloodstream infection and Ep-stein-Barr virus co-infection in non-coastal area:one case report
Jianmei CHEN ; Feng WANG ; Dong LING ; Shuyue ZHAO
Chinese Journal of Infection Control 2025;24(11):1660-1662
This paper reports a death due to septic shock caused by Shewanella algae bloodstream infection and Epstein-Barr virus(EBV)co-infection in an elderly male patient who had no history of seawater exposure.She-wanella algae was identified in blood culture.Antimicrobial susceptibility testing showed that the strain was sus-ceptible to meropenem while resistance to ceftriaxone.EBV sequence was detected by metagenomic next-generation sequencing(mNGS)of blood specimen.Despite meropenem combined with antiviral and anti-shock treatment,the patient still rapidly progressed to multiple organ failure and died.This case suggests that Shewanella algae infec-tion relevant to freshwater environment exposure should be alerted,co-infection with EBV can exacerbate the severi-ty of sepsis,and potential risk of treatment failure should be paid attention in clinical practice despite carbapenems susceptibility confirmed by testing.
10.Analysis on risk factors of adverse events after non-sedated esophagogastroduo-denoscopy
Shuyue YANG ; Sifan LIU ; Xu JI ; Mengran ZHAO ; Zheng ZHANG ; Peng LI
Journal of Capital Medical University 2025;46(4):676-681
Objective To investigate the risk factor for adverse events(AEs)after non-sedated esophagogastroduodenoscopy(EGD).Methods The data on clinical manifestations,adverse events after non-sedated EGD and common risk factors were collected and retrospectively analyzed with statistical methods in patients who underwent non-sedated EGD from May 2018 to June 2019.These patients were divided into AEs group and non-AEs group.Results Of 2 384 patients,57.67%(1 375/2 384)presented with nausea,12.79%(305/2 384)vomiting,and 5.79%(138/2 384)presented with pharyngalgia.Multivariate Logistic regression analysis was performed.Advanced age(≥65 years old)(OR=0.683,95%CI:0.506-0.921)was protective factors for nausea after non-sedated EGD.Hypertension(OR=1.361,95%CI:1.026-1.806),overweight(OR=1.399,95%CI:1.154-1.695),obesity(OR=2.594,95%CI:1.760-3.823)and inspection duration>15 min(OR=3.107,95%CI:2.296-4.206)were independent risk factors for nausea after non-sedated EGD.Advanced age(OR=0.393,95%CI:0.221-0.699)and imported equipment(OR=0.697,95%CI:0.546-0.890)were protective factors for vomiting after non-sedated EGD.Moreover,inspection duration>15 min(OR=1.641,95%CI:1.008-2.699)was independent risk factors for vomiting after non-sedated EGD.There was no difference in success rate of non-sedated EGD between two groups(P<0.05).Conclusion Hypertension,overweight and obesity were independent risk factors for nausea after non-sedated EGD.The advanced age and imported equipment were protective factors for vomiting after non-sedated EGD.In addition,inspection duration over 15 min is a risk factor for AEs such as nausea and vomiting after nonsedative EGD.Whether AEs occurred or not is non-related to success rate of non-sedated EGD.

Result Analysis
Print
Save
E-mail